Income Statement Qingdao Kingking Applied Chemistry Co., Ltd.
Equities
002094
CNE000001PS4
Household Products
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.170 CNY | -1.36% | -0.91% | -42.74% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 5.45B | 4B | 3.12B | 2.92B | 2.5B | |||||
Other Revenues, Total | 24.44M | 1.46M | 34.79M | 29.69M | 5.17M | |||||
Total Revenues | 5.47B | 4B | 3.15B | 2.95B | 2.51B | |||||
Cost of Goods Sold, Total | 4.65B | 3.75B | 2.73B | 2.7B | 2.27B | |||||
Gross Profit | 821M | 253M | 418M | 250M | 242M | |||||
Selling General & Admin Expenses, Total | 665M | 558M | 412M | 324M | 194M | |||||
Provision for Bad Debts | 21.73M | 35.89M | 35.79M | 90.65M | -429K | |||||
R&D Expenses | 35.84M | 32.37M | 39.29M | 37.06M | 34.23M | |||||
Other Operating Expenses | 14.36M | 12.39M | 9.04M | 10.52M | 10.96M | |||||
Other Operating Expenses, Total | 737M | 638M | 496M | 463M | 238M | |||||
Operating Income | 84.16M | -385M | -77.46M | -213M | 3.84M | |||||
Interest Expense, Total | -79.39M | -62.33M | -50.98M | -45.62M | -54.13M | |||||
Interest And Investment Income | 396M | 113M | 126M | 6.23M | 125M | |||||
Net Interest Expenses | 317M | 51.05M | 74.7M | -39.39M | 71.2M | |||||
Currency Exchange Gains (Loss) | - | - | - | - | - | |||||
Other Non Operating Income (Expenses) | -39.8M | -120M | 433K | -227M | -65.73M | |||||
EBT, Excl. Unusual Items | 361M | -454M | -2.32M | -479M | 9.31M | |||||
Impairment of Goodwill | -249M | -190M | - | -69.52M | -11.26M | |||||
Gain (Loss) On Sale Of Investments | - | -4.15M | -4.7M | -305M | 11.57M | |||||
Gain (Loss) On Sale Of Assets | -34.9K | 30.15K | -61.15K | -3.51M | 176K | |||||
Asset Writedown | -146K | -719K | -4.07M | -2.08M | - | |||||
Other Unusual Items | 55.29M | 6.72M | 7.19M | 1.81M | 15.59M | |||||
EBT, Incl. Unusual Items | 167M | -642M | -3.97M | -857M | 25.4M | |||||
Income Tax Expense | 118M | -71.62M | 13.62M | 17.96M | 16.42M | |||||
Earnings From Continuing Operations | 48.47M | -571M | -17.59M | -875M | 8.98M | |||||
Net Income to Company | 48.47M | -571M | -17.59M | -875M | 8.98M | |||||
Minority Interest | -27.3M | 142M | 33.93M | 66.36M | 1.45M | |||||
Net Income - (IS) | 21.17M | -429M | 16.34M | -809M | 10.42M | |||||
Net Income to Common Incl Extra Items | 21.17M | -429M | 16.34M | -809M | 10.42M | |||||
Net Income to Common Excl. Extra Items | 21.17M | -429M | 16.34M | -809M | 10.42M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.03 | -0.62 | 0.02 | -1.17 | 0.02 | |||||
Basic EPS - Continuing Operations | 0.03 | -0.62 | 0.02 | -1.17 | 0.02 | |||||
Basic Weighted Average Shares Outstanding | 706M | 692M | 690M | 691M | 521M | |||||
Net EPS - Diluted | 0.03 | -0.62 | 0.02 | -1.17 | 0.02 | |||||
Diluted EPS - Continuing Operations | 0.03 | -0.62 | 0.02 | -1.17 | 0.02 | |||||
Diluted Weighted Average Shares Outstanding | 706M | 692M | 690M | 691M | 521M | |||||
Normalized Basic EPS | 0.28 | -0.21 | 0.05 | -0.34 | 0.01 | |||||
Normalized Diluted EPS | 0.28 | -0.21 | 0.05 | -0.34 | 0.01 | |||||
Dividend Per Share | - | - | - | - | - | |||||
Payout Ratio | 389.42 | -14.27 | 442.44 | -5.27 | 492.15 | |||||
Supplemental Items | ||||||||||
EBITDA | 119M | -353M | -46.42M | -177M | 34.1M | |||||
EBITA | 96.61M | -374M | -66.6M | -203M | 5.81M | |||||
EBIT | 84.16M | -385M | -77.46M | -213M | 3.84M | |||||
EBITDAR | 171M | -311M | -10.53M | -148M | 47.84M | |||||
Total Revenues (As Reported) | 5.47B | 4B | 3.15B | 2.95B | 2.51B | |||||
Effective Tax Rate - (Ratio) | 70.96 | 11.15 | -342.94 | -2.1 | 64.66 | |||||
Total Current Taxes | 137M | 7.13M | 30.58M | 3.3M | 12.47M | |||||
Total Deferred Taxes | -18.41M | -78.75M | -16.97M | 14.66M | 3.95M | |||||
Normalized Net Income | 198M | -142M | 32.48M | -233M | 7.27M | |||||
Interest on Long-Term Debt | 7.52M | - | - | - | - | |||||
Non-Cash Pension Expense | - | 299K | 4.38M | 3.14M | 8.05K | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 71.93M | 76.32M | 41.52M | 17.85M | 19.07M | |||||
Selling and Marketing Expenses | 411M | 311M | 189M | 128M | 74.23M | |||||
General and Administrative Expenses | 203M | 205M | 187M | 168M | 106M | |||||
Research And Development Expense From Footnotes | 35.84M | 32.37M | 39.29M | 37.06M | 34.23M | |||||
Net Rental Expense, Total | 51.65M | 42.39M | 35.89M | 29.21M | 13.73M | |||||
Imputed Operating Lease Interest Expense | 22.03M | 19.11M | 15.39M | 11.31M | 5.56M | |||||
Imputed Operating Lease Depreciation | 29.62M | 23.28M | 20.5M | 17.9M | 8.17M |